Vibrio vulnificus

Background

  • Gram negative bacterium living in marine environments
  • Leading cause of shellfish-associated death in US

Vibrio species


Clinical Features

Differential Diagnosis

Skin and Soft Tissue Infection

Look-A-Likes

Nausea and vomiting

Critical

Emergent

Nonemergent

Evaluation

  • Generally clinical diagnosis, though blood cultures may assist in ultimate diagnosis and vibrio PCR testing exists[3]
  • CT and surgical consult if concern for nec fas
  • CBC, BMP, LFTs if significant vomiting

Management

  • Severe infections should be treated with immediate antibiotics and ICU admission
  • May require aggressive surgical debridement
  • Doxycycline 100 mg IV or PO BID + ceftazidime 2g IV q8h[4]

Antibiotic Sensitivities[5]

Category Antibiotic Sensitivity
PenicillinsPenicillin GX1
Penicillin VX1
Anti-Staphylocccal PenicillinsMethicillinX1
Nafcillin/OxacillinX1
Cloxacillin/Diclox.X1
Amino-PenicillinsAMP/AmoxX1
Amox-ClavX1
AMP-SulbX1
Anti-Pseudomonal PenicillinsTicarcillinX1
Ticar-ClavX1
Pip-TazoX1
PiperacillinX1
CarbapenemsDoripenemX1
ErtapenemX1
ImipenemX1
MeropenemX1
AztreonamX1
FluroquinolonesCiprofloxacinX1
OfloxacinX1
PefloxacinX1
LevofloxacinX1
MoxifloxacinX1
GemifloxacinX1
GatifloxacinX1
1st G CephaloCefazolinX1
2nd G. CephaloCefotetanX1
CefoxitinX1
CefuroximeX1
3rd/4th G. CephaloCefotaximeX1
CefizoximeX1
CefTRIAXoneX1
CeftarolineX1
CefTAZidimeX1
CefepimeX1
Oral 1st G. CephaloCefadroxilX1
CephalexinX1
Oral 2nd G. CephaloCefaclor/LoracarbefX1
CefproxilX1
Cefuroxime axetilX1
Oral 3rd G. CephaloCefiximeX1
CeftibutenX1
Cefpodox/Cefdinir/CefditorenX1
AminoglycosidesGentamicinI
TobramycinI
AmikacinI
ChloramphenicolX2
ClindamycinX1
MacrolidesErythromycinX1
AzithromycinX1
ClarithromycinX1
KetolideTelithromycinX1
TetracyclinesDoxycyclineS+
MinocyclineS+
GlycylcyclineTigecyclineX1
DaptomycinR
Glyco/LipoclycopeptidesVancomycinX1
TeicoplaninX1
TelavancinX1
Fusidic AcidR
TrimethoprimX1
TMP-SMXX1
Urinary AgentsNitrofurantoinX1
FosfomycinX1
OtherRifampinX1
MetronidazoleR
Quinupristin dalfoppristinX1
LinezolidX1
ColistimethateX1

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

See Also

References

  1. Choi HJ, Lee DK, Lee MW, Choi JH, Moon KC, Koh JK. Vibrio vulnificus septicemia presenting as purpura fulminans. J Dermatol. Jan 2005;32(1):48-51.
  2. Choi HJ, Lee DK, Lee MW, Choi JH, Moon KC, Koh JK. Vibrio vulnificus septicemia presenting as purpura fulminans. J Dermatol. Jan 2005;32(1):48-51.
  3. https://emedicine.medscape.com/article/1055523-workup
  4. https://www.aafp.org/afp/2007/0815/p539.html
  5. Sanford Guide to Antimicrobial Therapy 2014


Disposition

  • Contingent on presentation, admit if severe or significant comorbidities

See Also

References

    This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.